Revolutionize Your Omics Experiments

Gene Inspector is our GenAI-enabled Research Intelligence platform, which allows scientists to perform efficient literature review of potential gene candidates in minutes. It generates insights based on context-rich information digested from multiple scientific publications. Scientists can get insights into up to 100 genes in one shot and gain valuable data from omics experiments.

Gene Inspector transforms your approach to drug discovery by enhancing the comprehension of omics experiment results through advanced AI technologies. By optimizing research study design and streamlining target identification processes, Gene Inspector helps you avoid the pitfalls of poor target selection—a common factor in clinical trial failures.

Gene Inspector is valuable for evaluating results produced from genomics (eg: Next Generation Sequencing), transcriptomics (eg: RNA-Seq experiments) and proteomics studies like LC-MS (Liquid Chromatography-Mass Spectrometry).

Gene Inspector leverages Generative AI technologies to generate summarized information on potential gene biomarkers like biological expression, role in disease pathophysiology, prediction of response to clinical interventions and many more. Utilizing the prioritization feature, scientists can streamline biomarker discovery process and foster development of novel diagnostic modalities.

Identification of a promising target that is ‘druggable’ and relevant to the disease is a herculean task. Gene Inspector provides a comprehensive overview of prospective biological targets with information on therapeutic relevance to disease phenotype, biological expression, druggability profiles, etc. using data digested from scientific publications. This approach delivers rich context to omics experiment results and guides scientists to choose the right target with the desired effect.

Gene Inspector generates summaries based on the top relevant scientific publications indexed in the PubMed database.